Discover how both heat and cold can impact psoriatic arthritis symptoms and learn which is best for your relief.

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Bristol Myers Squibb (BMS) has shared positive top-line results from two late-stage studies of its oral TYK2 inhibitor ...

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...

If you suffer from psoriasis, cooler weather could be bad news. Learn how high and low humidity levels can affect psoriasis ...

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...

JNJ-2113 is under clinical development by Johnson & Johnson and currently in Phase III for Psoriatic Arthritis.

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis ...

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

MoonLake Immunotherapeutics (MLTX) announced that patients have been screened in three new trials across three new indications to evaluate ...

Chronic kidney disease is not uncommon among patients with PsA, with risk factors including diabetes and NSAID use, while ...